For the first time, AIDS researchers, service providers and willing primary care physicians have an FDA-approved drug to reduce the risk of contracting HIV.
HIV prevention drug brings opportunities and challenges
by Joseph Duggan Lyons on July 23, 2012 in National, News, Special Reports ·
About author
Joseph is a Chicagoan by way of Iowa. He's a @MedillSchool grad who loves tacos, organic vegetables and travel. Tweet him at @josephdlyons.
Share this article
Recommended
















